Cologne – Specialty chemicals company LANXESS has successfully completed a debottlenecking project resulting in a 15 percent increase in global production capacity of its Additin RC 4000 series of corrosion inhibition additives.
The additional capacities are a result of process synergies identified and realized following LANXESS’s 2017 acquisition of Chemtura Corporation, which expanded its lubricant additives portfolio and global production network.
“With LANXESS’s increased footprint from the Chemtura acquisition, we were able to unlock process synergies between our production sites in Mannheim, Germany and West Hill, Canada to increase output of our corrosion inhibitors products to meet market demand and further enhance our global production network,” said Martin Saewe, Head of the Lubricant Additives business line in LANXESS’s Additives (ADD) business unit.
“The global corrosion inhibitor market is growing and we have seen increasing demand for LANXESS specialty additives products due to their unique performance and technical advantages relative to other product offerings in the market,” Saewe adds. “While we are committed to supply security for our customers, we are also looking toward the future with new product developments in the pipeline to meet new performance requirements and stricter regulations.”
LANXESS’s Additin Corrosion Inhibition (CI) product range includes calcium sulfonate, carboxylate, succinic acid, and phosphoric acid-based specialty products. They work by being adsorbed on the polar metal surface to form a water-repellent and protective film that protects against corrosion. Main applications include power transmission oils, industrial oils, metalworking fluids, anti-corrosion oils, and greases.
The Additives (ADD) business unit is part of LANXESS’s Specialty Additives segment, which recorded sales of EUR 1.60 billion in fiscal year 2017.
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person’s officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.
LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017. The company currently has about 15,500 employees in 33 countries and is represented at 59 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.